Kestra Medical Technologies, Ltd.
NASDAQ:KMTS · NASDAQ Global Select
-$0.07 today
Vol 0.37M · Avg 0.33M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+24.56%
Period High
$28.01
Period Low
$14.46
Latest
$19.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B

Neogen Corporation
NASDAQ:NEOG
$1.97B

Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.80B

NovoCure Limited
NASDAQ:NVCR
$1.71B

STAAR Surgical Company
NASDAQ:STAA
$1.42B

Precigen, Inc.
NASDAQ:PGEN
$1.39B

BioLife Solutions, Inc.
NASDAQ:BLFS
$1.27B

Wave Life Sciences Ltd.
NASDAQ:WVE
$1.16B

Azenta, Inc.
NASDAQ:AZTA
$1.05B

Evotec SE
NASDAQ:EVO
$921.71M
What is the latest KMTS filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does KMTS have?
Intrinsic Alpha currently shows 20 recent filings for KMTS.
Explore More
Continue the stock analysis
Jump to another research area for this company.